European guideline for the management of genital herpes

International Journal of STD and AIDS

Volumn 12, Issue SUPPL. 3, 2001, Pages 34-39

  Patel, R ^a   Barton, S E ^a   Brown, D ^a   Cowan, F M ^a   Kinghorn, G R ^a   Munday, P E ^a   Scoular, A ^a   Timmins, D ^a   Whittaker, M ^a   Woolley, P ^a  

^a ROYAL SOUTH HANTS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; CIDOFOVIR; FAMCICLOVIR; FOSCARNET; TRIFLURIDINE; VALACICLOVIR;

EUROPE; GENITAL HERPES; INFECTION RISK; PATIENT COUNSELING; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECURRENT INFECTION; REVIEW; VIRUS SHEDDING; VIRUS TRANSMISSION;

EID: 0034788457     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462011924092     Document Type: Review

References (26)

1. Frequency and reactivation of nongenital recurrences among patients with genital herpes simplex virus
2. Risk factors for the sexual transmission of genital herpes
3. The acquisition of herpes simplex virus during pregnancy
4. Recurrence rates in genital herpes after symptomatic first-episode infection
5. Herpes simplex virus
6. Herpes simplex virus detection from genital lesions; a comparative study using antigen detection (HerpChek) and culture
7. Comparison of cell culture with an amplified enzyme immunoassay for diagnosing genital herpes simplex infection
8. Role of type specific herpes simplex virus serology in the diagnosis and management of genital herpes
9. Treatment of primary first-episode genital herpes simplex virus infections with acyclovir: Results of topical, intravenous and oral therapy
10. Valaciclovir versus acyclovir in the treatment of first-episode genital herpes infection. Results of an international, multicenter, double-blind, randomized clinical trial
11. Risk of recurrence after treatment of first-episode genital herpes with intravenous acyclovir
12. Efficacy of oral acyclovir in the treatment of initial and recurrent genital herpes
13. A large-scale, placebo controlled, dose ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis
14. Patient-initiated, twice daily oral famciclovir for early recurrent genital herpes: A randomized, double-blind multicenter trial
15. Valaciclovir for the suppression of recurrent genital HSV infection: A placebo controlled study of once daily therapy
16. Long-term acyclovir suppression of frequently recurring genital herpes simplex virus infection. A multicenter double-blind trial
17. Oral famciclovir for suppression of recurrent genital herpes simplex virus infection in women. A multicenter, double-blind, placebo-controlled trial
18. Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir
19. Asymptomatic reactivation of Herpes simplex virus in women after the first episode of genital herpes
20. Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections
21. A randomised double blind placebo controlled trial of cidofovir gel for the treatment of acyclovir-unresponsive mucocutaneous herpes simplex virus infection in patients with AIDS
22. Frequency of acquisition of first episode genital infection with herpes simplex virus infection from symptomatic and asymptomatic source contacts
23. Development of clinically recognizable genital lesions among women previously identified as having 'asymptomatic' herpes simplex virus type 2 infection
24. Acyclovir suppression to prevent cesarean delivery after first-episode genital herpes
25. Use of routine viral cultures at delivery to identify neonates exposed to herpes simplex virus
26. Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes